Elemer Piros
Stock Analyst at Rodman & Renshaw
(0.77)
# 2112
Out of 5,230 analysts
142
Total ratings
29.13%
Success rate
-2.55%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BTAI BioXcel Therapeutics | Initiates Coverage On: Buy | 65 | 1.9 | 3321.05% | 1 | Mar 19, 2025 | |
FBLG FibroBiologics | Initiates Coverage On: Buy | 12 | 1.21 | 891.74% | 1 | Dec 12, 2024 | |
THAR Tharimmune | Initiates Coverage On: Buy | 17 | 1.2 | 1316.67% | 1 | Dec 6, 2024 | |
QNCX Quince Therapeutics | Initiates Coverage On: Buy | 11 | 1.18 | 832.2% | 1 | Oct 29, 2024 | |
MNPR Monopar Therapeutics | Initiates Coverage On: Buy | 50 | 43.99 | 13.66% | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | 1.05 | 1519.05% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 0.29 | 7486.21% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 107 107 | 1.61 | 6545.96% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 14 14 | 0.42 | 3233.33% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 67 67 | 1.59 | 4113.84% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 43 | 2.27 | 1794.27% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 6.25 | 188% | 7 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 8 | 0.84 | 792.86% | 3 | Sep 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 1.5 | 900% | 8 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 21 | 6.33 | 231.75% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 | 3.86 | 884.46% | 9 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 | 1.66 | 2309.64% | 2 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | 0.64 | 681.25% | 5 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 114 | 7.18 | 1487.74% | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 200 | 3.02 | 6522.52% | 6 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 23 | n/a | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 33 | 9.47 | 248.47% | 3 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 | n/a | n/a | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 40 | 17.41 | 129.75% | 7 | Apr 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 40 | 1.02 | 3821.57% | 3 | Jan 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 37 | 1.72 | 2051.16% | 1 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 38 32 | 3.98 | 704.02% | 2 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 128 124 | n/a | n/a | 7 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | n/a | n/a | 1 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 77 | 12.94 | 495.05% | 2 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 0.69 | 10044.93% | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 240 | n/a | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 21 24 | n/a | n/a | 4 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 225 75 | n/a | n/a | 2 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 50 | 13.34 | 274.81% | 5 | Nov 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 33 | 2.67 | 1135.96% | 2 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 191 186 | n/a | n/a | 4 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 3 | Jul 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 26 | 7.39 | 251.83% | 3 | May 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 115 | n/a | n/a | 3 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 21 | n/a | n/a | 1 | Nov 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 28 | 167.98 | -83.33% | 1 | Sep 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 17 | n/a | n/a | 2 | Aug 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 70 65 | n/a | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 525 850 | 5.25 | 16090.48% | 1 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 204 84 | n/a | n/a | 2 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | n/a | n/a | 1 | Jul 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 35 21 | 7.82 | 168.54% | 2 | Jul 12, 2017 |